Home
Hans Jørgen Aarstad's picture

Hans Jørgen Aarstad

Professor
  • E-mailHans.Aarstad@uib.no
  • Visitor Address
    Haukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • 2020. Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children. Journal of Infectious Diseases. 1528-1537.
  • 2019. Quality of life in persons with hearing loss: a study of patients referred to an audiological service. International Journal of Audiology. 696-703.
  • 2019. Periodontal status at diagnosis predicts non-disease-specific survival in a geographically defined cohort of patients with oropharynx squamous cell carcinoma. Acta Oto-Laryngologica. 309-315.
  • 2019. Hearing as an Independent Predictor of Postural Balance in 1075 Patients Evaluated for Dizziness . Otolaryngology and head and neck surgery. 478-484.
  • 2019. EORTC Quality of Life Questionnaire Head and Neck (H&N)-35 scores from H&N squamous cell carcinoma patients obtained at diagnosis and at 6, 9 and 12 months following diagnosis predict 10-year overall survival. European Archives of Oto-Rhino-Laryngology. 3495-3505.
  • 2019. An fMRI-study on single-sided deafness: Spectral-temporal properties and side of stimulation modulates hemispheric dominance. NeuroImage: Clinical. 1-11.
  • 2018. Tumor stromal desmoplasia and inflammatory response uniquely predict survival with and without stratification for HPV tumor infection in OPSCC patients. Acta Oto-Laryngologica. 1035-1042.
  • 2018. Generic quality of life in persons with hearing loss: A systematic literature review. BMC Ear, Nose and Throat Disorders. 1-13.
  • 2018. Correlation between excessive daytime sleepiness (EDS) and self-reported and objective nasal characteristics. Rhinology. 316-322.
  • 2018. Clinical application and psychometric properties of a norwegian questionnaire for the self-assessment of communication in quiet and adverse conditions using two revised APHAB subscales. Journal of american academy of audiology. 25-34.
  • 2018. Acoustic voice analysis and maximum phonation time in relation to voice handicap index score and larynx disease. Journal of Voice. 1-9.
  • 2017. Health-related Quality of Life as Studied by EORTC QLQ and Voice Handicap Index Among Various Patients With Laryngeal Disease. Journal of Voice. 251.e17-251.e26.
  • 2017. General health-related quality of life scores from head and neck squamous cell carcinoma patients obtained throughout the first year following diagnosis predicted up to 10-year overall survival. European Archives of Oto-Rhino-Laryngology. 207-217.
  • 2016. Primary surgery results in no survival benefit compared to primary radiation for oropharyngeal cancer patients stratified by high-risk human papilloma virus status. European Archives of Oto-Rhino-Laryngology. 11 pages.
  • 2016. Live attenuated influenza vaccine in children induces b-cell responses in tonsils. Journal of Infectious Diseases. 722-731.
  • 2016. In vitro monocyte IL-6 secretion levels following stimulation with autologous spheroids derived from tumor or benign mucosa predict long-term survival in head and neck squamous cell carcinoma patients. Scandinavian Journal of Immunology. 211-219.
  • 2016. Development of a disease-specific health-related quality of life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in renal cell carcinoma patients. Acta Oncologica. 349-356.
  • 2016. Congenital laryngomalacia is related to exerciseinduced laryngeal obstruction in adolescence. Archives of Disease in Childhood. 443-448.
  • 2015. The Norwegian Voice Handicap Index (VHI-N) patient scores are dependent on voice-related disease group. European Archives of Oto-Rhino-Laryngology. 2897-2905.
  • 2015. Preoperative high levels of serum vascular endothelial growth factor are a prognostic marker for poor outcome after surgical treatment of renal cell carcinoma. Scandinavian journal of urology. 388-394.
  • 2015. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). 305-314.
  • 2015. Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children. Journal of Infectious Diseases. 1541-1549.
  • 2015. In vitro-stimulated IL-6 monocyte secretion and in vivo peripheral blood T lymphocyte activation uniquely predicted 15-year survival in patients with head and neck squamous cell carcinoma. PLOS ONE.
  • 2015. Health-related quality of life, personality and choice of coping are related in renal cell carcinoma patients. Scandinavian journal of urology. 282-289.
  • 2014. The impact of HPV infection, smoking history, age and operability of the patient on disease-specific survival in a geographically defined cohort of patients with oropharyngeal squamous cell carcinoma. Acta Oto-Laryngologica. 964-973.
  • 2014. The impact of HPV infection on survival in a geographically defined cohort of oropharynx squamous cell carcinoma (OPSCC) patients in whom surgical treatment has been one main treatment. Acta Oto-Laryngologica. 636-645.
  • 2014. Perioperative cytokine response to infection associated with elective arterial surgery. European Journal of Vascular and Endovascular Surgery. 116-122.
  • 2014. Level of distress predicts subsequent survival in successfully treated head and neck cancer patients: a prospective cohort study. Acta Oto-Laryngologica. 211-219.
  • 2014. Health-related quality of life in long-term survivors after renal cancer treatment. Scandinavian Journal of Urology and Nephrology. 52-64.
  • 2013. Stability of distress and health-related quality of life as well as relation to neuroticism, coping and TNM stage in head and neck cancer patients during follow- up. Acta Oto-Laryngologica. 209-217.
  • 2013. Prediction of survival by pretreatment health-related quality-of-life scores in a prospective cohort of patients with head and neck squamous cell carcinoma. Archives of Otolaryngology - Head & Neck Surgery. 14-20.
  • 2013. Prediction of 5 year survival from level of perceived distress in newly diagnosed head and neck squamous cell carcinoma patients. Oral Oncology. 964-969.
  • 2013. OK-432-stimulated chemokine secretion from human monocytes depends om MEK1/2, and involves p38 MAPK and NF-kB phosphorylation, in vitro. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). 299-310.
  • 2013. Distinct single cell signal transduction signatures in leukocyte subsets stimulated with khat extract, amphetamine-like cathinone, cathine or norephedrine. BMC Pharmacology & Toxicology. 13 pages.
  • 2013. Diagnostic yield of biopsies of cervical lymph nodes using a large (14-gauge) core biopsy needle. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). 1119-1130.
  • 2013. Cross-cultural adaption and translation of the voice handicap index into Norwegian. Folia Phoniatrica et Logopaedica. 234-240.
  • 2013. Comorbidity is an independent predictor of health-related quality of life in a longitudinal cohort of head and neck cancer patients. European Archives of Oto-Rhino-Laryngology. 1721-1728.
  • 2012. Personality, choice of coping and T stage predict level of distress in head and neck cancer patients during follow-up. European Archives of Oto-Rhino-Laryngology. 2121-2128.
  • 2012. Cross-cultural adaption and translation of the voice handicap index into Norwegian. Folia Phoniatrica et Logopaedica. 234-240.
  • 2011. Maturation of monocyte derived dendritic cells with OK432 boosts IL-12p70 secretion and conveys strong T-cell responses. BMC Immunology. 10 pages.
  • 2011. MAPKs ERK and p38, but not JNK Phosphorylation, modulate IL-6 and TNF-alpha secretion following OK-432 in vitro stimulation of purified human monocytes. Scandinavian Journal of Immunology. 114-125.
  • 2011. Health-related quality of life scores in long-term head and neck cancer survivors predict subsequent survival: a prospective cohort study. Clinical Otolaryngology. 361-368.
  • 2011. Health-related quality of life in long-term survivors after high-dose chemoradiotherapy followed by surgery in esophageal cancer. Diseases of the esophagus. 39-47.
  • 2011. Head and neck specific Health Related Quality of Life scores predict subsequent survival in successfully treated head and neck cancer patients: A prospective cohort study. Oral Oncology. 974-979.
  • 2011. Exercise-induced laryngeal obstruction: natural history and effect of surgical treatment. European Archives of Oto-Rhino-Laryngology. 1485-1492.
  • 2011. Distress, quality of life, neuroticism and psychological coping are related in head and neck cancer patients during follow-up. Acta Oncologica. 390-398.
  • 2011. Choice of psychological coping in laryngectomized, head and neck squamous cell carcinoma patients versus multiple sclerosis patients. European Archives of Oto-Rhino-Laryngology. 97-115.
  • 2010. In vitro cholesteatoma growth and secretion of cytokines. Acta Oto-Laryngologica. 815-819.
  • 2009. Chemokines are secreted by monocytes following OK-432 (lyophilized Streptococcus pyogenes) stimulation. BMC Immunology.
  • 2009. Audiovisual assessment of exercise-induced laryngeal obstruction: reliability and validity of observations. European Archives of Oto-Rhino-Laryngology. 1929-1936.
  • 2008. Stimulated monocyte IL-6 secretion predicts survival of patients with head and neck squamous cell carcinoma. BMC Cancer. 10 pages.
  • 2008. Personality and choice of coping predict quality of life in head and neck cancer patients during follow-up. Acta Oncologica. 879-890.
  • 2008. Co-culture of head and neck squamous cell carcinoma spheroids with autologous monocytes predicts prognosis. Scandinavian Journal of Immunology. 392-399.
  • 2007. Tumour-associated macrophages secrete IL-6 and MCP-1 in head and neck squamous cell carcinoma tissue. Acta Oto-Laryngologica. 532-539.
  • 2007. TNF-alpha is Secreted by Monocytes in Transit to become Macrophages, but not by Peripheral Blood Monocytes, following OK-432 (Lyophilized S. pyogenes) Stimulation. Scandinavian Journal of Immunology. 684-693.
  • 2007. Quality of life, drinking to cope, alcohol consumption and smoking in successfully treated HNSCC patients. Acta Oto-Laryngologica. 1091-1098.
  • 2006. The amount of treatment versus quality of life in patients formerly treated for head and neck squamous cell carcinomas. European Archives of Oto-Rhino-Laryngology. 9-15.
  • 2006. Presence of activated T lymphocytes in peripheral blood of head and neck squamous cell carcinoma patients predicts impaired prognosis. Acta Oto-Laryngologica. 1326-1333.
  • 2005. Viable head and neck tumor spheroids stimulate in vitro autologous monocyte MCP-1 secretion through soluble substances and CD14/lectin-like receptors. European Archives of Oto-Rhino-Laryngology. 953-960.
  • 2005. Psychological coping style versus disease extent, tumour treatment and quality of life in seccessfully treated head and neck squamous cell carcinoma patients. Clinical Otolaryngology. 530-538.
  • 2005. Mood, anxiety and sense of humor in head and neck cancer patients in relation to disease stage, prognosis and quality of life. Acta Oto-Laryngologica. 557-565.
  • 2005. Head and neck squamous cell carcinoma spheroid- and monocyte spheroid-stimulated IL-6 and monocyte chemotactic protein-1 secretion are related to TNM stage, inflammatory state and tumor macrophage density. Acta Oto-Laryngologica. 1097-1104.
  • 2003. The personality and quality of life in HNSCC patients following treatment. European Journal of Cancer. 1852-1860.
  • 2003. The personality and quality of life in HNSCC patients following treatment. European Journal of Cancer. 1852-1860.
  • 2003. The personality and quality of life in HNSCC patients following treatment. European Journal of Cancer. 1852-1860.
  • 2003. Gene expression profile in oral squamous cell carcinomas and matching normal oral mucosal tissues from black Africans and white Caucasians: the case of the Sudan vs. Norway. Oral Oncology. 37-48.
  • 2002. Relation between mood, social support and the quality of life in patients with laryngectomies. European Archives of Oto-Rhino-Laryngology. 197-204.
  • 2002. Personality traits in head and neck squamous cell carcinoma patients in relation to the disease state, disease extent and prognosis. Acta Oto-Laryngologica. 892-899.
  • 2002. Mechanisms for monocyte activation in co-culture with autologous tumor spheroids. Cellular Immunology. 11-21.
  • 2001. Monocyte and monocyte-derived macrophage secretion of MCP-1 in co-culture with autologous malignant and benign control fragment spheroids. Cancer Immunology and Immunotherapy. 300-306.
  • 2001. Human Autologous Monocytes and Monocyte-Derived Macrophages in Co-Culture with Carcinoma F-Spheroids Secrete IL-6 by a Non-CD 14-Dependent Pathway. Scandinavian Journal of Immunology. 162-170.
  • 2000. Peripheral Blood T-Lymphocyte and Monocyte Function and Survival in Patients with Head and Neck Carcinoma. The Laryngoscope. 402-407.
  • 2000. Monocytes Secrete Interleukin-6 When Co-Cultured In Vitro with Benign or Malignant Autologous Fragment Spheroids from Squamous Cell Carninoma Patients. Scandinavian Journal of Immunology. 271-278.
  • 2000. Monocytes Secrete Interleukin-6 When Co-Cultured In Vitro with Benign or Malignant Autologous Fragment Spheroids from Squamous Cell Carninoma Patients. Scandinavian Journal of Immunology. 271-278.
  • 1999. Peripheral blood mononuclear cell (PBMC) responsiveness in patients with head and neck cancer in relation to tumour stage and prognosis. Acta Oto-Laryngologica. 281-284.
  • 1999. Peripheral Blood Mononuclear Cell (PBMC)Responsiveness in Patients with Head and Neck Cancer in Relation to Tumour Stage and Prognosis. Acta Oto-Laryngologica. 281-284.
  • 1999. Ex vivo interleukin (IL)-1beta, IL-6, IL-12 and tumor necrosis factor-alfa responsiveness with monocytes from patients with head and neck carcinoma. European Archives of Oto-Rhino-Laryngology. 250-256.
  • 1999. Ex vivo IL-1_b, IL-6, IL-12 and TNF-_a responsiveness with monocytes from patients with head and neck carcinoma. European Archives of Oto-Rhino-Laryngology. 250-256.
  • 1998. Disease stage related in vitro responsiveness of peripheral blood T-lymphocytes in patients with head and neck carcinoma. Acta oto-laryngologica. Supplementum. 887-891.
  • 1998. Disease stage related in vitro responsiveness of peripheral blood T-lymphocytes in patients with head and neck carcinoma. Acta oto-laryngologica. Supplementum. 887-891.
  • 1997. In vitro T-lymphocyte function in head and neck cancer patients. European Archives of Oto-Rhino-Laryngology. 318-322.
  • 1997. In vitro T-lymphocyte function in head and neck cancer patients. European Archives of Oto-Rhino-Laryngology. 318-322.
  • 1995. T lymfocytt funksjon hos ØNH-cancer og kontroll pasienter. Forhandlinger NOLF. 85-90.
Academic lecture
  • 2019. Personality and choice of coping are important for self-reported health-related quality of life in patients with renal tumors prior to radical surgery.
  • 2019. Level of distress is closely related to personality and choice of coping in patients with renal tumors prior to radical surgery.
  • 2015. Cellular immune responses after live attenuated influenza vaccination in children, a clinical trial.
  • 2013. Psykometrisk validering av et diagnosespesifikt livskvalitets- skjema (HRQoL,) ment brukt sammen med det generelle EORTC livskvalitests- skjemaet (QLQ) på nyrekreft-pasienter.
  • 2013. Psychometric validation of a disease-specific Health Related Quality of Life (HRQoL) questionnaire intended to be used in conjunction with the general European Organization of Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) in Renal Cell Carcinoma patients.
  • 2012. Survival and Quality og Life Following Surgery and Postoperative Radiotherapy versus Radiotherapy alone in a Geographically Defined Cohort of Oropharyngeal Carcinoma Patients. 23nd Annual Meeting og the Scandinavian Sociesty for Head and Neck Oncology.
  • 2012. GHQ scores predict uniquely survival in successfully treated head and neck cancer patients: a prospective study.
  • 2012. Distress scores predict uniquely survival in successfully treated head and neck cancer patients:a prospective study.
  • 2012. Distress scores predict uniquely survival in successfully treated head and neck cancer patients: a prospective study.
  • 2011. Psychosocial factors and health related quality of life in former head and neck cancer patients.
  • 2011. Psychosocial factors and Health reted Quality of Life in former Head and Neck cancer patients.
  • 2011. Pre-treatment comorbidity predicts pre-and post treatment health-related quality of life sum scores.
  • 2011. Neuroticism predicts pre-and posttreatment health-related quality of life sum scores.
  • 2011. Do health related quality of life score predict survival in former head and neck cancer patients?
  • 2010. Distress and quality of life in head and neck cancer patients during follow up.
  • 2005. Tumour associated macrophages secrete IL-6 within HNSCC tissue.
  • 2005. Livskvalitet hos pasienter behandlet for hode/hals kreftsykdom.
  • 2005. Livskvalitet hos pasienter behandlet for hode/hals kreftsykdom.
  • 2004. Personality and quality of life in relation to quantity of treatment in patients With HNSCC.
  • 2004. Monocytes in head and neck carcinoma patients.
  • 2004. Monocytes in head and neck carcinoma patients.
  • 2003. Immunological aspects in patients with head and neck carcinoma.
  • 2003. Immunologic aspects in patients with head &neck carcinoma.
  • 2003. Immunologic aspects in patients with head &neck carcinoma.
  • 2003. Immunologic aspects in patients with head & neck carcinoma.
  • 2003. Immunologic aspects in patients with head & Neck carcinoma.
  • 2003. HNSCC spheroids monokine secretion and autologous monocyte co-culture activation vs TNM stage, inflammatory stage and macrophage denity.
  • 2003. HNSCC spheroids monokine secretion and autologous monocyte co-culture activation versus tnm stage, inflammatory state and macrophage density.
  • 2003. HNSCC spheroids monokine secretion and autologous monocyte co-culture activation versus TNM stage, inflammatory state and macrophage density.
  • 2002. Quality of life, mood and social support in laryngetomized patients.
  • 2001. Quality of life in laryngectomees in relation to mood and social support : Where upper airway and digestive tract meet.
  • 2001. Personality traits in relation to stage and prognosis in head and neck carcinoma patients.
  • 2001. Mechanisms for monocyte activation in co-culture with autologous fragment spheroids from head and neck squamous cell carcinomas.
  • 2001. Interaction between cancer disease and the immune system in patients with head and neck carcinoma.
  • 2000. Function of peripheral mononuclear cell (PBMC) in relation to nodal stage and prognosis in head and neck cancer (HNSCC) patients.
  • 2000. Function of peripheral mononuclear cell (PBMC) in relation to nodal stage and prognosis in head and neck cancer (HNSCC) patients.
  • 1998. Prognostic value of <EM>in vitro</EM> T lymphocyte and monocyte function in patients with head and neck carcinoma.
  • 1998. Fragment spheroids with squamous cell benign or malignant cell stimulati <EM>in vito</EM> autologous monocytes to secrete IL-6, but not TNF.
  • 1997. Monocyte activation in autologous co-culture with malignant and benign mucosa fragment spheroids from head and neck cancer patients.
  • 1997. Monocyte activation in autologous co-culture with malignant and benign mucosa fragment spheroids from head and neck cancer patients.
  • 1997. In vitro T lymphocyte and monocyte function in head and neck carcinomia patients in relation to tumor stage.
  • 1997. In vitro T lymphocyte and monocyte function in head and neck carcinomia patients in relation to tumor stage.
  • 1993. In vitro immune function with cells from head and neck cancer and control patients.
Doctoral dissertation
  • 2018. Functional-structural reorganization of the neuronal network for auditory perception in subjects with unilateral hearing loss.
  • 2015. Health-related Quality of Life, Distress and Psychosocial Factors in Head and Neck and Renal Cancer Patients. Quality of Life in HNSCC and RCC patients.
  • 2013. Health Related Quality of Life and Distress Scores Predict Survival in Head and Neck Cancer Patients.
Abstract
  • 2013. Serum VEGF in patients with renal tumours and low contrast enhancement on ct can be used to predict survival and recurrence. Scandinavian Journal of Urology and Nephrology. 32-33.
  • 2013. Health related quality of life (HRQoL), personality and choice of coping is associated in renal cell carcinoma patients. Scandinavian Journal of Urology and Nephrology. 33-34.
  • 2011. MAPK ERK, p38, and JNK-Dependent Chemokine Secretion Following OK-432 Stimulation of Human Monocytes In Vitro. Scandinavian Journal of Immunology. 363-363.
  • 2010. Maturation of Monocyte Derived Dendritic Cells With OK432 Leads to Altered Expression of Surface Markers. Scandinavian Journal of Immunology. 504-504.
  • 2008. Maturation of monocyte derived dendritic cells with OK432 leads to altered expression of surface markers. Scandinavian Journal of Immunology. 217-217.
  • 2005. Gene expression profile in oral and head and neck carcinomas between patients from Sudan and Norway. Oral Oncology. 157-158.
Poster
  • 2013. Health related quality of life (HRQoL) personality and choice of coping is associated in renal cell carcinoma patinets.
  • 2012. Pre-Treatment Health Related Quality of Life Scores Predict Survival in a Prospective Cohort of Head and Neck Squamous Cell Carsinoma Patients.
  • 2002. Gene expression profile in oral squamous cell carcinomas and matching normal oral mucosal tissues from black Africans and white Caucasians: The case of the Sudan vs. Norway.
Academic literature review
  • 2016. Functional-structural reorganisation of the neuronal network for auditory perception in subjects with unilateral hearing loss: Review of neuroimaging studies. 73-79.
  • 2010. Mononuclear phagocytes in head and neck squamous cell carcinoma. 335-344.

More information in national current research information system (CRIStin)